1. |
- Mohanty, Soumitra, et al.
(author)
-
Diabetes downregulates the antimicrobial peptide psoriasin and increases E. coli burden in the urinary bladder
- 2022
-
In: Nature Communications. - : Springer Nature. - 2041-1723. ; 13
-
Journal article (peer-reviewed)abstract
- Diabetes is known to increase susceptibility to infections, partly due to impaired granulocyte function and changes in the innate immunity. Here, we investigate the effect of diabetes, and high glucose on the expression of the antimicrobial peptide, psoriasin and the putative consequences for E. coli urinary tract infection. Blood, urine, and urine exfoliated cells from patients are studied. The influence of glucose and insulin is examined during hyperglycemic clamps in individuals with prediabetes and in euglycemic hyperinsulinemic clamped patients with type 1 diabetes. Important findings are confirmed in vivo in type 2 diabetic mice and verified in human uroepithelial cell lines. High glucose concentrations induce lower psoriasin levels and impair epithelial barrier function together with altering cell membrane proteins and cytoskeletal elements, resulting in increasing bacterial burden. Estradiol treatment restores the cellular function with increasing psoriasin and bacterial killing in uroepithelial cells, confirming its importance during urinary tract infection in hyperglycemia. In conclusion, our findings present the effects and underlying mechanisms of high glucose compromising innate immunity. Patients with diabetes have an increased susceptibility to infections. Here the authors show that high glucose impairs innate immunity through reduced levels of the antimicrobial peptide psoriasin and impaired epithelial barrier function, resulting in an increased risk of urinary tract infection.
|
|
2. |
- Taloyan, Marina, et al.
(author)
-
Cardiovascular risk factors in Assyrians/Syrians and native Swedes with type 2 diabetes: a population-based epidemiological study.
- 2009
-
In: Cardiovascular Diabetology. - : Springer Science and Business Media LLC. - 1475-2840. ; 8:Nov 12
-
Journal article (peer-reviewed)abstract
- BACKGROUND: A large number of people throughout the world have diabetes and the prevalence is increasing. Persons with diabetes have a twice higher risk of cardiovascular disease than those without diabetes. There is a lack of studies focusing on cardiovascular risk factors in Assyrians/Syrians with type 2 diabetes. The aim of this study is to estimate the prevalence of some cardiovascular risk factors among Assyrians/Syrians and native Swedes with type 2 diabetes and to study whether the association between ethnicity and cardio-vascular risk factors remains after adjustment for age, gender, employment status and housing tenure. METHODS: In the Swedish town of Södertälje 173 Assyrians/Syrians and 181 ethnic Swedes with type 2 diabetes participated in a study evaluating cardiovascular risk factors such as increased haemoglobin A1c (HbA1c), high blood lipids (total serum cholesterol and triglycerides), hypertension and high urinary albumin. The associations between the outcome variables and sociodemographic characteristics were estimated using unconditional logistic regression. RESULTS: The prevalence of increased triglycerides in Swedish-born subjects and Assyrian-Syrians was 61.5% and 39.7% respectively. Swedes had a prevalence of hypertension 76.8% compared to 57.8% in Assyrians/Syrians. In the final logistic models adjusted for gender, age, housing and employment the odds ratio (OR) for Swedish-born subjects for increased triglycerides was 2.80 (95% CI1.61-4.87) and for hypertension 2.32 (95% CI 1.35-4.00) compared to Assyrians-Syrians. CONCLUSION: Ethnic Swedes had higher prevalence of increased triglycerides and hypertension than Assyrians/Syrians. Total cholesterol, HbA1c and urinary albumin did not differ between the two ethnic groups.
|
|
3. |
- Taloyan, Marina, et al.
(author)
-
Ethnic differences in dissatisfaction with sexual life in patients with type 2 diabetes in a Swedish town.
- 2010
-
In: BMC Public Health. - : Springer Science and Business Media LLC. - 1471-2458. ; 10
-
Journal article (peer-reviewed)abstract
- BACKGROUND: The first aim of this study was to analyze whether self-reported satisfaction with one's sexual life was associated with ethnicity (Swedish and Assyrian/Syrian) in patients with type 2 diabetes. The second was to study whether the association between satisfaction with one's sexual life and ethnicity remained after controlling for possible confounders such as marital status, HbA1c, medication, and presence of other diseases. METHODS: This cross-sectional, questionnaire-based study was conducted at four primary health care centers in the Swedish town of Södertälje. A total of 354 persons (173 ethnic Assyrians/Syrians and 181 ethnic Swedes) participated. RESULTS: The total prevalence of self-reported dissatisfaction with one's sexual life in both groups was 49%. No significant ethnic differences were found in the outcome. In the final model, regardless of ethnicity, the odds ratio (OR) for self-reported dissatisfaction with one's sexual life in those ≥ 70 years old was 2.52 (95% CI 1.33-4.80). Among those living alone or with children, the OR was more than three times higher than for married or cohabiting individuals (OR = 3.10, 95% CI 1.60-6.00). Those with other diseases had an OR 1.89 times (95% CI 1.10-3.40) higher than those without other diseases. CONCLUSIONS: The findings demonstrate that almost half of participants were dissatisfied with their sexual life and highlight the importance of sexual life to people with type 2 diabetes. This factor should not be ignored in clinical evaluations. Moreover, the findings demonstrate that it is possible to include questions on sexual life in investigations of patients with type 2 diabetes and even in other health-related, questionnaire studies, despite the sensitivity of the issue of sexuality.
|
|
4. |
- Taloyan, Marina, et al.
(author)
-
Poor self-rated health in adult patients with type 2 diabetes in the town of Södertälje: A cross-sectional study.
- 2010
-
In: Scandinavian Journal of Primary Health Care. - : Informa UK Limited. - 0281-3432 .- 1502-7724. ; 28, s. 216-220
-
Journal article (peer-reviewed)abstract
- Abstract Objective. Several studies indicate that ethnicity may be a strong predictor of poor self-rated health (SRH). The aims of the present study were to investigate whether there was an association between ethnicity and poor SRH in subjects with type 2 diabetes and to determine if the association remained after adjusting for possible confounders such as age, gender employment, marital status, and education. Design. A cross-sectional study based on a patient population in the town of Södertälje. An unconditional logistic regression was performed to estimate the odds ratios (ORs) and 95% confidence intervals (95% CIs). Setting. Four primary health care centers. Subjects. A total of 354 individuals were included: Assyrian/Syrian-born (n = 173) and Swedish-born (n = 181). Results. The odds ratio for rating poor SRH for Assyrian/Syrian subjects with type 2 diabetes was 4.5 times higher (95% CI = 2.7-7.5) than for Swedish patients in a crude model. After adjusting for possible confounders, unemployed/retired people had 5.4 times higher odds for reporting poor SRH than employees (OR = 5.4; 95% CI = 2.3-12.5). Women had 1.8 times higher odds (95% CI = 1.0-3.0) for reporting poor SRH than men. In the final model poor SRH among Assyrians/Syrians decreased but still remained significant (OR=3.7; 95% CI = 2.5-6.6). Conclusions. The findings in this study are important for planning primary health care services. They highlight the crucial importance of being aware of the subjective health status of immigrants fleeing from war in the Middle East and resettling in Sweden.
|
|
5. |
- Taloyan, Marina, et al.
(author)
-
Sexual dysfunction in Assyrian/Syrian immigrants and Swedish-born persons with type 2 diabetes
- 2012
-
In: BMC Research Notes. - : Springer Science and Business Media LLC. - 1756-0500. ; 5
-
Journal article (peer-reviewed)abstract
- BACKGROUND: Few studies have investigated sexual dysfunction in immigrant patients with type 2 diabetes in Sweden. The aim of this study was to examine the association between ethnicity and sexual dysfunction and to analyze if this association remains after adjusting for explanatory variables including age, marital status, HbA1c, triglycerides, and hypertension. This cross-sectional study was conducted at four primary health care centers in the Swedish town of Sodertalje. A total of 354 persons with type 2 diabetes (173 Assyrians/Syrians and 181 Swedish-born patients) participated in the survey. The main outcome measure was the self-reported presence of sexual dysfunction based on two questions, one regarding loss of ability to have sexual intercourse and the other loss of sexual desire. Response rates were 78% and 86%, respectively. FINDINGS: The total prevalence of loss of ability to have intercourse was 29.5%. In the multivariate models, the odds of loss of ability to have intercourse was significantly higher in the oldest age group (OR = 5.80; 95% CI, 2.33--14.40), in men (OR = 3.33; 95% CI, 1.33--8.30), and in unmarried individuals (OR = 2.40; 95% CI, 1.02--5.70). The odds of reporting loss of sexual desire was higher in Assyrians/Syrians than in Swedish-born patients and increased from 2.00 in the age- and gender-adjusted model to 2.70 in the fully adjusted model when all confounders were taken into account. CONCLUSIONS: Sexual dysfunction appears to be more common in Assyrians/Syrians than in Swedish-born patients. Health care workers should actively ask about sexual function in their patients with type 2 diabetes.
|
|
6. |
- Tovi, Jonas
(author)
-
Insulin treatment of elderly type 2 diabetic patients
- 1998
-
Doctoral thesis (other academic/artistic)abstract
- In this study, the effect of improved metabolic control through insulin treatment was investigated in elderly patients with type 2 diabetes with secondary failure of oral treatment. Forty, consecutive, elderly patients (mean age 75.3 (5.9) (mean and SD), range 67-86 years) were studied. They were randomised to insulin treatment (n=22) or to continue using sulfonylurea treatment (n= 18). There was a drop- out of five patients. The remaining patients were re-examined every six months for one year. At the start of the study, the two groups were similar. In the insulin-treated group, the fasting blood-glucose value fell from 13.8 (2. 1) to 8.9 (2.8) (p<0.001) and 9.7 (1.9) (p<0.001) mmol/L after 6 and 12 months, respectively, using one or two doses of NPH insulin, mean 0.53 (0.24) IU per kilogram of body weight and day. The HbA1c fell from 9.3 (1.4) to 7.2 (0.8) (p<0.00 1) and 7.3 (1.1) (p<0.001)%, but the body weight increased from 73 (14) to 75 (13) (p<0.05) and 76 (14) (p<0.01) kg. In the sulfonylurea- treated group, the fasting blood-glucose value was unchanged, 13.1 (2.3), 12.4 (2.7) and 12.1 (2.2) mmol/L at the start and after 6 and 12 months, respectively. The HbAlc values were 9.1 (1.2), 8.6 (1.4) and 9.3 (1.5)%. The body weight decreased from 78 (15) to 77 (16) and 76 (16) (p<0.05) kg. In starting insulin treatment, patients paid 5.5 (2.2) visits and made 6.1 (3.8) phone calls for dose adjustments during a total time of 3.1 (0.8) hours and during a period of 48 (19) days. The cost of starting insulin treatment at the health- care centre was SEK 1,107 (at 1995 values), compared with SEK 6,066 at the hospital's day-care clinic. In the insulin-treated patients, the 24-hour, ambulatory blood pressures did not change, in spite of improved metabolic control, probably owing to the counteracting effect of increased body weight Well-being and symptoms did not improve as the metabolic control improved, but insulin treatment reduced the symptoms of hyperglycaemia without increasing those of hypoglycaemia. Neuropathy was present in 56% of the patients, compared with 15% among healthy controls (p<0.001). In most patients, neuropathy was asymptomatic. More patients had signs of carpal-tunnel syndrome. Improvement was not seen after one year of insulin treatment, nor was progression seen in the sulfonylurea-treated group of patients. Most patients (65%) had eye-ground changes, but insulin treatment did not cause more progression of retinopathy or macular oedema than oral treatment. Improved metabolic control did not affect the mean levels of insulin growth factor-I (IQF-I) or insulin growth factor binding protein-1 (IGFBP-1). High levels of IGFBP-1 indicated a need of insulin treatment, resulting in improved metabolic control and insulin sensitivity. In conclusion, a large number of elderly diabetic patients with secondary failure of oral treatment had signs of neuropathy and retinopathy. They could effectively and at a low cost be put on insulin at a health-care centre. The resulting improvement in metabolic control did not affect blood-pressure levels and did not cause progression of retinopathy or improvement in neuropathy. The patients with high IGFBP-1 levels seem to be those who will benefit the most from insulin treatment.
|
|